In the wild, suitors vie for affections with grand displays of dance or feathery flourish. Humans, on the other hand, make first impressions with opening lines. A group of European researchers gathered 30 heterosexual singles between the ages of 20 and 40 for two speed-dating events to study the competitive behaviors involved in sexual attraction.… Read More »
Anti-obesity drug Saxenda has been one of Novo Nordisk’s key growth drivers lately—and apparently, a Korean wholesaler noticed. The pharmaceutical middleman allegedly smuggled the popular drug into China, where it’s not yet approved. Korean regulators are investigating the wholesaler for allegedly hawking Saxenda in China, Korea Biomedical Review reported, citing multiple sources. A Novo spokeswoman confirmed to FiercePharma… Read More »
The National Institutes of Health is making new investments into the BRAIN Initiative, which will include new studies of opioids. New funds of $ 220 million to support 200 new research awards have been awarded, bringing total 2018 program support to more than $ 400 million, which is 50 percent more than the amount spent… Read More »
It’s Friday, everyone! And that means another Primal Blueprint Real Life Story from a Mark’s Daily Apple reader. If you have your own success story and would like to share it with me and the Mark’s Daily Apple community please contact me here. I’ll continue to publish these each Friday as long as they keep… Read More »